Moreover, the significant association of ITGAV expression and immune infiltrating cells (e.g., CD8+T cell and neutrophil) in certain cancers (e.g., colon cancer [10] and gastric cancer [11]) has been reported before, implying its potential in immunotherapy. This evidence concerns the gene CD8A and cancer.